Simultaneous bilateral mastectomy and RRSO for BRCA2-positive non-invasive breast cancer in Japan: a case report and analysis of initial experience

ConclusionsWe encountered a case in which cancer treatment and risk-reducing surgery were performed at the same time for a pathogenic variant carrier who was very anxious about developing cancer. Surveillance of cancer-freeBRCA1/2 mutation carriers and expansion of insurance coverage for surgery are important future issues.
Source: Hereditary Cancer in Clinical Practice - Category: Cancer & Oncology Source Type: research